Role of cerebral cortex in the neuropathology of Huntington's disease
暂无分享,去创建一个
[1] L. Raymond,et al. Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load , 2007, The Journal of physiology.
[2] H. Herzog,et al. Cerebral glucose consumption measured by PET in patients with and without psychiatric symptoms of Huntington's disease , 1989, Psychiatry Research.
[3] Stephen C. Fowler,et al. Dysregulation of coordinated neuronal firing patterns in striatum of freely behaving transgenic rats that model Huntington's disease , 2010, Neurobiology of Disease.
[4] R C Burgess,et al. Event related potentials I , 1992, Clinical Neurophysiology.
[5] M. Guillermier,et al. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects , 2010, Human molecular genetics.
[6] E. Stern,et al. Functional Changes in Neocortical Activity in Huntington's Disease Model Mice: An in vivo Intracellular Study , 2011, Front. Syst. Neurosci..
[7] P. Thompson,et al. The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement. , 1988, Brain : a journal of neurology.
[8] C. Markham,et al. Cerebral metabolism and atrophy in huntington's disease determined by 18FDG and computed tomographic scan , 1982, Annals of neurology.
[9] M. Beal,et al. The Energetics of Huntington's Disease , 2004, Neurochemical Research.
[10] I. Módy,et al. Pathological Cell-Cell Interactions Elicited by a Neuropathogenic Form of Mutant Huntingtin Contribute to Cortical Pathogenesis in HD Mice , 2005, Neuron.
[11] M. Stryker,et al. Development and Plasticity of the Primary Visual Cortex , 2012, Neuron.
[12] M. Deschenes,et al. Corticothalamic projections from layer V cells in rat are collaterals of long-range corticofugal axons , 1994, Brain Research.
[13] D. Mann,et al. The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy , 2004, Acta Neuropathologica.
[14] G. Reynolds,et al. Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease , 1986, Neuroscience Letters.
[15] A. Reiner,et al. Corticostriatal Projection Neurons – Dichotomous Types and Dichotomous Functions , 2010, Front. Neuroanat..
[16] Korbinian Brodmann,et al. Brodmann's localization in the cerebral cortex : the principles of comparative localisation in the cerebral cortex based on cytoarchitectonics , 2006 .
[17] R. Hales,et al. J Neuropsychiatry Clin Neurosci , 1992 .
[18] G. Rebec,et al. Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: Variations with behavioral state and repeated ascorbate treatment , 2006, Neuroscience.
[19] R. Ferrante,et al. Mouse models of Huntington's disease and methodological considerations for therapeutic trials. , 2009, Biochimica et biophysica acta.
[20] Henry Markram,et al. Diminished Activity-Dependent Brain-Derived Neurotrophic Factor Expression Underlies Cortical Neuron Microcircuit Hypoconnectivity Resulting from Exposure to Mutant Huntingtin Fragments , 2010, Journal of Pharmacology and Experimental Therapeutics.
[21] Lili Zhou,et al. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[22] A. Laverghetta,et al. Differential morphology of pyramidal tract‐type and intratelencephalically projecting‐type corticostriatal neurons and their intrastriatal terminals in rats , 2003, The Journal of comparative neurology.
[23] Mark Turmaine,et al. Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.
[24] Patrik Brundin,et al. Loss of SNAP‐25 and rabphilin 3a in sensory‐motor cortex in Huntington’s disease , 2007, Journal of neurochemistry.
[25] Carlos Cepeda,et al. Enhanced sensitivity to N‐methyl‐D‐aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease , 1999, Journal of neuroscience research.
[26] R. Llinás,et al. Disturbed Ca 2 signaling and apoptosis of medium spiny neurons in Huntington ’ s disease , 2005 .
[27] E G Jones,et al. Thalamic and brainstem contributions to large-scale plasticity of primate somatosensory cortex. , 1998, Science.
[28] W. Penfield,et al. SOMATIC MOTOR AND SENSORY REPRESENTATION IN THE CEREBRAL CORTEX OF MAN AS STUDIED BY ELECTRICAL STIMULATION , 1937 .
[29] O. Paulson,et al. Reduced regional cerebral blood flow in Huntington's disease studied by SPECT. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[30] S. W. Davies,et al. Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.
[31] Scott J Barton,et al. Altered Information Processing in the Prefrontal Cortex of Huntington's Disease Mouse Models , 2008, The Journal of Neuroscience.
[32] Kim A. Verwaest,et al. (1)H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington disease. , 2011, Biochimica et biophysica acta.
[33] Michael Falkenstein,et al. Alterations in Voluntary Movement Execution in Huntington's Disease Are Related to the Dominant Motor System — Evidence from Event-related Potentials , 2022 .
[34] Martin Parent,et al. Single‐axon tracing study of corticostriatal projections arising from primary motor cortex in primates , 2006, The Journal of comparative neurology.
[35] G. Johnson,et al. Mitochondrial Respiration and ATP Production Are Significantly Impaired in Striatal Cells Expressing Mutant Huntingtin* , 2005, Journal of Biological Chemistry.
[36] G. Rebec,et al. Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes. , 2012, Basal ganglia.
[37] H. Herzog,et al. Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. , 1990, Brain : a journal of neurology.
[38] H. Eichenbaum,et al. Oscillatory Entrainment of Striatal Neurons in Freely Moving Rats , 2004, Neuron.
[39] B. Stockwell,et al. Therapeutic approaches to preventing cell death in Huntington disease , 2012, Progress in Neurobiology.
[40] Y. Smith,et al. Microcircuitry of the direct and indirect pathways of the basal ganglia. , 1998, Neuroscience.
[41] K. Murphy,et al. Abnormal cortical synaptic plasticity in a mouse model of Huntington's disease , 2007, Brain Research Bulletin.
[42] He Li,et al. Mutant Huntingtin Causes Context-Dependent Neurodegeneration in Mice with Huntington's Disease , 2003, The Journal of Neuroscience.
[43] Steven M Hersch,et al. Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice , 2005, The Journal of comparative neurology.
[44] D. Zald,et al. Neuroscience and Biobehavioral Reviews Anatomical Insights into the Interaction of Emotion and Cognition in the Prefrontal Cortex , 2022 .
[45] S. Shipp. The importance of being agranular: a comparative account of visual and motor cortex , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.
[46] F. Clascá,et al. Thalamic input to distal apical dendrites in neocortical layer 1 is massive and highly convergent. , 2009, Cerebral cortex.
[47] Carlos Cepeda,et al. Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease. , 2006, Journal of neurophysiology.
[48] A. Lajtha,et al. Decreased brain N-acetylaspartate in Huntington's disease , 1992, Brain Research.
[49] P. Gubellini,et al. Role of glutamate transporters in corticostriatal synaptic transmission , 2009, Neuroscience.
[50] George V. Rebec,et al. Dysfunctional Behavioral Modulation of Corticostriatal Communication in the R6/2 Mouse Model of Huntington’s Disease , 2012, PloS one.
[51] Terry L. Jernigan,et al. Cerebral structure on MRI, part II: Specific changes in Alzheimer's and Huntington's diseases , 1991, Biological Psychiatry.
[52] Jane S. Paulsen,et al. CAG‐repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[53] Jane S. Paulsen,et al. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease , 2004, Neurology.
[54] S. Groiss,et al. Local field potential oscillations of the globus pallidus in Huntington's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[55] K. Jinnai,et al. Neurons of the motor cortex projecting commonly on the caudate nucleus and the lower brain stem in the cat , 1979, Neuroscience Letters.
[56] C. Blakemore,et al. Deficits in Experience-Dependent Cortical Plasticity and Sensory-Discrimination Learning in Presymptomatic Huntington's Disease Mice , 2005, The Journal of Neuroscience.
[57] C. Cepeda,et al. Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease , 2007, Molecular Neurodegeneration.
[58] A. Dale,et al. Regional and progressive thinning of the cortical ribbon in Huntington’s disease , 2002, Neurology.
[59] K. Marder,et al. Dietary intake in adults at risk for Huntington disease , 2009, Neurology.
[60] J. Martell. Chorea , 1954, The Canadian nurse.
[61] Thomas Walther,et al. Transgenic rat model of Huntington's disease. , 2003, Human molecular genetics.
[62] R. Llinás,et al. Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[63] György Buzsáki,et al. Synaptic plasticity and self-organization in the hippocampus , 2005, Nature Neuroscience.
[64] Bruce Fischl,et al. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. , 2008, Brain : a journal of neurology.
[65] M. Beal,et al. Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia , 1997, Annals of neurology.
[66] T. Videen,et al. Selective defect of in vivo glycolysis in early Huntington's disease striatum , 2007, Proceedings of the National Academy of Sciences.
[67] Hugo Merchant,et al. Functional impact of interneuronal inhibition in the cerebral cortex of behaving animals , 2012, Progress in Neurobiology.
[68] A Weindl,et al. Changes of NMDA Receptor Subunit (NR1, NR2B) and Glutamate Transporter (GLT1) mRNA Expression in Huntington's Disease—An In Situ Hybridization Study , 1997, Journal of neuropathology and experimental neurology.
[69] M. Hayden,et al. Body weight is modulated by levels of full-length huntingtin. , 2006, Human molecular genetics.
[70] Carlos Cepeda,et al. Full-Length Human Mutant Huntingtin with a Stable Polyglutamine Repeat Can Elicit Progressive and Selective Neuropathogenesis in BACHD Mice , 2008, The Journal of Neuroscience.
[71] Carlos Cepeda,et al. The corticostriatal pathway in Huntington's disease , 2007, Progress in Neurobiology.
[72] Bruce Fischl,et al. A tale of two factors: What determines the rate of progression in Huntington's disease? A longitudinal MRI study , 2011, Movement disorders : official journal of the Movement Disorder Society.
[73] Claire-Anne Gutekunst,et al. A YAC Mouse Model for Huntington’s Disease with Full-Length Mutant Huntingtin, Cytoplasmic Toxicity, and Selective Striatal Neurodegeneration , 1999, Neuron.
[74] Olaf Riess,et al. Behavioral and In Vivo Electrophysiological Evidence for Presymptomatic Alteration of Prefrontostriatal Processing in the Transgenic Rat Model for Huntington Disease , 2011, The Journal of Neuroscience.
[75] G. Rebec,et al. Neural correlates of unpredictability in behavioral patterns of wild-type and R6/2 mice , 2012, Communicative & integrative biology.
[76] A. M. Estrada-Sánchez,et al. Glycolysis Inhibition Decreases the Levels of Glutamate Transporters and Enhances Glutamate Neurotoxicity in the R6/2 Huntington′s Disease Mice , 2010, Neurochemical Research.
[77] H. Heinsen,et al. Cortical and striatal neurone number in Huntington's disease , 2004, Acta Neuropathologica.
[78] D. Geschwind,et al. In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons. , 2011, Human molecular genetics.
[79] G. Rebec,et al. Reduced expression of conditioned fear in the R6/2 mouse model of Huntington's disease is related to abnormal activity in prelimbic cortex , 2011, Neurobiology of Disease.
[80] R. Ferrante,et al. Experimental models of HD and reflection on therapeutic strategies. , 2011, International review of neurobiology.
[81] O. Foerster,et al. THE MOTOR CORTEX IN MAN IN THE LIGHT OF HUGHLINGS JACKSON'S DOCTRINES , 1936 .
[82] D. Sengelaub,et al. Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse , 2008, Neuroscience.
[83] M. Deschenes,et al. Corticostriatal projections from layer V cells in rat are collaterals of long-range corticofugal axons , 1996, Brain Research.
[84] A. Reiner,et al. Evidence for Differential Cortical Input to Direct Pathway versus Indirect Pathway Striatal Projection Neurons in Rats , 2004, The Journal of Neuroscience.
[85] I. Bezprozvanny,et al. Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium. , 2010, Future neurology.
[86] Luc Pellerin,et al. Does glutamate image your thoughts? , 2002, Trends in Neurosciences.
[87] P. Emson,et al. Glutamate Uptake is Reduced in Prefrontal Cortex in Huntington’s Disease , 2008, Neurochemical Research.
[88] Peng Yu,et al. Altered white matter microstructure in the corpus callosum in Huntington's disease: Implications for cortical “disconnection” , 2010, NeuroImage.
[89] G. Halliday,et al. Pyramidal Cell Loss in Motor Cortices in Huntington's Disease , 2002, Neurobiology of Disease.
[90] Lazaros C. Triarhou,et al. Cellular Structure of the Human Cerebral Cortex , 2009 .
[91] A. M. Estrada-Sánchez,et al. Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters , 2009, Neurobiology of Disease.
[92] C. Chen. Mitochondrial dysfunction, metabolic deficits, and increased oxidative stress in Huntington's disease. , 2011, Chang Gung medical journal.
[93] S. Shipp. Structure and function of the cerebral cortex , 2007, Current Biology.
[94] C. Blakemore,et al. Impaired learning-dependent cortical plasticity in Huntington's disease transgenic mice , 2004, Neurobiology of Disease.
[95] L. Menalled,et al. Knock-in mouse models of Huntington’s disease , 2005, NeuroRX.
[96] Rudolf Nieuwenhuys,et al. The insular cortex: a review. , 2012, Progress in brain research.
[97] C. Cepeda,et al. NMDA receptor function in mouse models of Huntington disease , 2001, Journal of neuroscience research.
[98] M. Hayden,et al. Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice. , 2012, Human molecular genetics.
[99] A. Mcgeorge,et al. The organization of the projection from the cerebral cortex to the striatum in the rat , 1989, Neuroscience.
[100] George V. Rebec,et al. Dysregulated Neuronal Activity Patterns Implicate Corticostriatal Circuit Dysfunction in Multiple Rodent Models of Huntington's Disease , 2011, Front. Syst. Neurosci..
[101] B R Rosen,et al. 1H NMR spectroscopy studies of Huntington's disease , 1998, Neurology.
[102] David S Tuch,et al. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures , 2006, Movement disorders : official journal of the Movement Disorder Society.
[103] D. Ehrnhoefer,et al. Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression. , 2010, Human molecular genetics.
[104] K. Murphy,et al. Impaired Long-Term Potentiation in the Prefrontal Cortex of Huntington’s Disease Mouse Models: Rescue by D1 Dopamine Receptor Activation , 2011, Neurodegenerative Diseases.
[105] L. Massieu,et al. Excitotoxic neuronal death and the pathogenesis of Huntington's disease. , 2008, Archives of Medical Research.
[106] O. Hansson,et al. Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice , 2001, The European journal of neuroscience.
[107] P. Hof,et al. Stereologic characterization and spatial distribution patterns of Betz cells in the human primary motor cortex. , 2003, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.
[108] E. Cattaneo,et al. Brain-derived neurotrophic factor in neurodegenerative diseases , 2009, Nature Reviews Neurology.
[109] D. Oorschot,et al. Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. , 2010, Brain : a journal of neurology.
[110] B. Shaby,et al. Identifying polyglutamine protein species in situ that best predict neurodegeneration , 2011, Nature chemical biology.
[111] E. Giltay,et al. Psychiatric disorders in Huntington's disease: a 2-year follow-up study. , 2012, Psychosomatics.
[112] G. Rebec,et al. Altered Neural and Behavioral Dynamics in Huntington's Disease: An Entropy Conservation Approach , 2012, PloS one.
[113] D. Sax,et al. Evidence of cortical metabolic dysfunction in early Huntington's disease by single‐photon‐emission computed tomography , 1996, Movement disorders : official journal of the Movement Disorder Society.
[114] Yannick Jeantet,et al. Changes in striatal procedural memory coding correlate with learning deficits in a mouse model of Huntington disease , 2011, Proceedings of the National Academy of Sciences.
[115] M. Cudkowicz,et al. Degeneration of pyramidal projection neurons in Huntington's disease cortex , 1990, Annals of neurology.
[116] M. Chesselet,et al. Electrophysiological and Morphological Changes in Striatal Spiny Neurons in R 6 / 2 Huntington ’ s Disease Transgenic Mice , 2001 .
[117] I. Módy,et al. Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease , 2008, Neuroscience.
[118] N. Ichinohe. Small-Scale Module of the Rat Granular Retrosplenial Cortex: An Example of the Minicolumn-Like Structure of the Cerebral Cortex , 2011, Front. Neuroanat..
[119] J. Cummings,et al. Huntington's disease. , 1997, The Psychiatric clinics of North America.
[120] D. Craufurd,et al. Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease. , 2012, The Journal of neuropsychiatry and clinical neurosciences.
[121] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[122] Samuel P. Burns,et al. Comparisons of the Dynamics of Local Field Potential and Multiunit Activity Signals in Macaque Visual Cortex , 2010, The Journal of Neuroscience.
[123] T. Powell,et al. The cortico-striate projection in the monkey. , 1970, Brain : a journal of neurology.
[124] R W Guillery,et al. Distinct functions for direct and transthalamic corticocortical connections. , 2011, Journal of neurophysiology.
[125] O. Bandmann,et al. The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-Analysis , 2012, PLoS currents.
[126] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[127] G. M. Halliday,et al. Regional Specificity of Brain Atrophy in Huntington's Disease , 1998, Experimental Neurology.
[128] S. Small,et al. R6/2 Huntington's Disease Mice Develop Early and Progressive Abnormal Brain Metabolism and Seizures , 2012, The Journal of Neuroscience.
[129] Marc H. Schieber,et al. Descending control of movement , 2003 .
[130] R. S. Williams,et al. Morphometric analysis of the prefrontal cortex in Huntington's disease , 1991, Neurology.
[131] M. Chesselet,et al. Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. , 2001, Journal of neurophysiology.
[132] A. Rasmussen,et al. Huntington disease in children: genotype-phenotype correlation. , 2000, Neuropediatrics.
[133] J. Lisman. Bursts as a unit of neural information: making unreliable synapses reliable , 1997, Trends in Neurosciences.
[134] K. Miller. Understanding layer 4 of the cortical circuit: a model based on cat V1. , 2003, Cerebral cortex.
[135] F. Walker. Huntington's disease , 2007, The Lancet.
[136] Scott J Barton,et al. Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease. , 2008, Journal of neurophysiology.
[137] M. MacDonald,et al. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. , 2004, Human molecular genetics.
[138] P. Harper. The epidemiology of Huntington's disease , 1992, Human Genetics.
[139] D. Borchelt,et al. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. , 1999, Human molecular genetics.
[140] Frank C. Hoppensteadt,et al. Bursts as a unit of neural information: selective communication via resonance , 2003, Trends in Neurosciences.
[141] Christopher A. Ross,et al. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease , 1991, Neuroscience Letters.
[142] J. Szentágothai. The ‘module-concept’ in cerebral cortex architecture , 1975, Brain Research.
[143] A. Young,et al. A polymorphic DNA marker genetically linked to Huntington's disease , 1983, Nature.
[144] Michelle K. Lupton,et al. The Hdh Q150/Q150 knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes , 2007, Brain Research Bulletin.
[145] J. Vonsattel,et al. Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease , 1988, Journal of neuropathology and experimental neurology.
[146] C. Cepeda,et al. Changes in Cortical and Striatal Neurons Predict Behavioral and Electrophysiological Abnormalities in a Transgenic Murine Model of Huntington's Disease , 2001, The Journal of Neuroscience.
[147] Jacki Y. Brown,et al. Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease. , 2006, Human molecular genetics.